Platelet to Lymphocyte Ratio Can be a Predictor of Infarct-Related Artery Patency in Patients with ST-Segment Elevation Myocardial Infarction

Angiology

Volumn 66, Issue 9, 2015, Pages 831-836

  Yayla, Çaʇrl ^a   Akboʇa, Mehmet Kadri ^a   Canpolat, Uʇur ^a   Akyel, Ahmet ^b   Yayla, Kadriye Gayretli ^b   Doʇan, Mehmet ^b   Yeter, Ekrem ^b   Aydoʇdu, Sinan ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Cardiology Clinic   (Turkey)

Author keywords

infarct related artery patency; platelet to lymphocyte ratio; ST segment elevation myocardial infarction

Indexed keywords

GLUCOSE; TROPONIN I; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFARCT RELATED ARTERY PATENCY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL LYMPHOCYTE RATIO; PLATELET LYMPHOCYTE RATIO; PREDICTION; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR PATENCY; AGED; ANGIOCARDIOGRAPHY; BLOOD; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY OCCLUSION; LYMPHOCYTE; LYMPHOCYTE COUNT; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; THROMBOCYTE; THROMBOCYTE COUNT; TURKEY;

AGED; BIOMARKERS; BLOOD PLATELETS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY OCCLUSION; CORONARY VESSELS; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY; VASCULAR PATENCY;

EID: 84941130234     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319715573658     Document Type: Article

References (35)

1. Maseri A, Fuster V,. Is there a vulnerable plaque? Circulation. 2003; 107 (16): 2068-2071.
2. Fuentes QE, Fuentes QF, Andres V, Pello OM, Font de Mora J, Palomo GI,. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets. 2013; 24 (4): 255-262
3. Brodie BR, Stuckey TD, Hansen C,. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol. 2000; 85 (1): 13-18.
4. Dogan M, Akyel A, Bilgin M,. Can admission neutrophil to lymphocyte ratio predict infarct-related artery patency in ST-Segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2015; 21 (2): 172-176.
5. Sahin DY, Gur M, Elbasan Z,. Predictors of preinterventional patency of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of neutrophil to lymphocyte ratio and uric acid level. Exp Clin Cardiol. 2013; 18 (2): e77-e81.
6. Elbasan Z, Gur M, Sahin DY,. Association of mean platelet volume and pre- and postinterventional flow with infarct-related artery in ST-segment elevation myocardial infarction. Angiology. 2013; 64 (6): 440-446.
7. Breet NJ, van Werkum JW, Bouman HJ,. The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction. Thromb Haemost. 2011; 106 (2): 331-336.
8. Celik T, Kaya MG, Akpek M,. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-Segment elevation myocardial infarction. Angiology. 2015; 66 (2): 155-162.
9. Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG,. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost. 2011; 9 (1): 49-56.
10. Ly HQ, Kirtane AJ, Murphy SA,. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol. 2006; 98 (1): 1-5
11. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP,. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997; 79 (6): 812-814.
12. Horne BD, Anderson JL, John JM,. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005; 45 (10): 1638-1643.
13. Acar G, Kalkan ME, Avci A,. The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Clin Appl Thromb Hemost. 2015; 21 (5): 462-468.
14. Azab B, Shah N, Akerman M, McGinn JT Jr,. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012; 34 (3): 326-334.
15. Balta S, Ozturk C,. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2014: 1-2. doi: 10.3109/09537104.2014.979340.
16. Thygesen K, Alpert JS, White HD,. Universal definition of myocardial infarction. Circulation. 2007; 116 (22): 2634-2653.
17. Mehta RH, Harjai KJ, Cox D,. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003; 42 (10): 1739-1746.
18. Nunez J, Nunez E, Bodi V,. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008; 101 (6): 747-752.
19. Akpek M, Kaya MG, Uyarel H,. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 2011; 219 (1): 334-341.
20. Lamas GA, Flaker GC, Mitchell G,. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation. 1995; 92 (5): 1101-1109.
21. Stone GW, Cox D, Garcia E,. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001; 104 (6): 636-641.
22. En N, Afsar B, Ozcan F,. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Atherosclerosis. 2013; 228 (1): 203-210.
23. Cura FA, L'Allier PL, Kapadia SR,. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol. 2001; 88 (2): 124-128.
24. Libby P, Ridker PM, Maseri A,. Inflammation and atherosclerosis. Circulation. 2002; 105 (9): 1135-1143.
25. von Hundelshausen P, Schmitt MM,. Platelets and their chemokines in atherosclerosis-clinical applications. Front Physiol. 2014; 5: 294.
26. Falk E,. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006; 47 (8 suppl): C7-C12.
27. Suades R, Padro T, Vilahur G, Badimon L,. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost. 2012; 108 (6): 1208-1219.
28. Serebruany VL, Malinin AI, Callahan KP,. Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy. Am Heart J. 2003; 145 (4): 636-642.
29. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ,. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation. 1998; 97 (1): 19-22
30. Nikolsky E, Grines CL, Cox DA,. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol. 2007; 99 (8): 1055-1061.
31. Yilmaz S, Sen F, Unal S,. Usefulness of the platelet-to-lymphocyte ratio to predict bare metal stent restenosis. Scand Cardiovasc J. 2014: 1-6. doi:10.3109/14017431.2014.989537.
32. Ugur M, Gul M, Bozbay M,. The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention. Blood Coagul Fibrinolysis. 2014; 25 (8): 806-811.
33. Akkaya E, Gul M, Ugur M,. Platelet to lymphocyte ratio: a simple and valuable prognostic marker for acute coronary syndrome. Int J Cardiol. 2014; 177 (2): 597-598.
34. Gary T, Pichler M, Belaj K,. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013; 8 (7): e67688.
35. Kurtul A, Murat SN, Yarlioglues M,. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction. Coron Artery Dis. 2014; 25 (2): 159-166.